Subscribe
Subscribe to IHE
Institute of Health Economics logo
My IHE Login
  • About IHE
    • About
    • History
    • Board of Directors
    • Partnerships & Affiliations
    • Lay Advisory Committee
    • Staff Directory
    • Careers
  • Research & Programs
    • Health Technology Assessment
    • Innovation and Industry Engagement
    • Health Economics
    • Knowledge Transfer
    • Research Partnerships
    • FASD Initiatives
    • Research Methodology Development
  • Publications
  • Knowledge Transfer
    • IHE Innovation Forum Series
    • Consensus Development Conference Series
    • AI/IHE Health Policy Speaker Series
    • Roundtables/Workshops
    • Conferences
  • News & Events
    • News
    • Upcoming Events
  • Contract Our Services
  • Contact
    • Contact Us & Subscribe
Home / Advanced Search

Advanced Search

Result Type

  • Publications
    • All Publications
    • Books
    • Consensus Statements
    • Economic Reports
    • Health Technology Assessments /
      Systematic Reviews
    • Health Topic Overviews / Scoping Reviews
    • Journal Articles
    • Methodology Papers
    • Overview of Systematic Reviews
    • Rapid Reviews
    • Statistics Handbooks
    • Summary Reports
  • Other Resources
    • All Resources
    • Backgrounders
    • Clinical Practice Guidelines
    • Clinical Tools
    • Event Proceedings
    • Patient Resources
    • Presentations
    • Programs
  • News/Events
  • General Content

Years

  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 1996-2009
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
    • 1997
    • 1996

Topics

  • Cancer
  • Chronic Diseases / Disorders
  • Diabetes
  • Diagnosis
  • Fetal Alcohol Spectrum Disorder (FASD)
  • Health Economics / Healthcare Costs
  • Health Measurement Tools
  • Health Policy
  • Healthcare Services
  • Infectious Diseases
  • Maternal and Child Health
  • Mental Health
  • Other
  • Pharmaceuticals
  • Prevention
  • Quality of Life
  • Screening
  • Surveillance
  • Telehealth
  • Therapy

Authors

  • Brown, Jasmine
  • Chojecki, Dagmara
  • Corabian, Paula
  • Escober-Doran, Carissa
  • Guo, Bing
  • Harstall, Christa
  • Husereau, Don
  • Institute of Health Economics, IHE
  • Jacobs, Philip
  • Jonsson, Egon
  • Moga, Carmen
  • Nguyen, Thanh
  • Ohinmaa, Arto
  • Scott, Ann
  • Sproule, John
  • Thompson, Angus
  • Tjosvold, Lisa
  • Waye, Arianna
  • Yan, Charles
  • Zheng, Yufei

The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.

If you cannot find the publication or report you are seeking, please contact us at info@ihe.ca. Thank you!

Refine your search by clicking filters to the left.

Results for: Screening

Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics

May 23, 2017

| Thanh Nguyen, Ilke Akpinar, Jennifer Gratrix, Sabrina Plitt, Petra Smyczek, Ron Read, Philip Jacobs, Tom Wong, Ameeta E Singh

Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strategies among women attending sexually transmitted infection clinics in Alberta, Canada: universal urogenital-only screening (UG-only),…

Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

May 12, 2016

| Anderson Chuck, Thanh Nguyen, James Wesenberg, Rhada Chari, Robert Wilson, Selikke Janes-Kelley

Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…

Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria,sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency

March 23, 2016

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…

Post policy implementation review (PPIR) of rapid fetal fibronectin testing for preterm labour in Alberta

July 07, 2015

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an assessment of how the adoption of fFN testing in Alberta impacted the clinical management of preterm labour and healty system resources. This was also an opportunity to retroactively use the Post Policy Implementation Framework to evaluate a specific…

First and second trimester prenatal screening update

August 31, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…

Effectiveness of Screening for Endemic Antibiotic Resistant Organisms (AROs) in Hospital Settings

July 18, 2014

| Ken Bond, Lisa Tjosvold, Christa Harstall

Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…

Consensus Statement on Surveillance & Screening for AROs (Antimicrobial-Resistant Organisms)

June 20, 2014

Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…

Low dose computed tomography for the screening of lung cancer in adults

May 30, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…

Transcutaneous Bilirubinometry for the Screening of Neonatal Hyperbilirubinemia

April 03, 2013

| IHE Institute of Health Economics

Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…

The Effectiveness and Safety of Preschool Hearing Screening Programs

November 23, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…

The Safety and Effectiveness of Preschool Vision Screening

November 05, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…

The Safety and Efficacy/Effectiveness of Using Automated Testing Devices for Universal Newborn Hearing Screening: An Update

October 14, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…

First and Second Trimester Prenatal Screening for Trisomies 13, 18, and 21, and Open Neural Tube Defects

September 01, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…

Cost-effectiveness of 21 alternative cervical cancer screening strategies.

April 12, 2010

| Anderson Chuck

  OBJECTIVES: The aim of this study is to assess the cost-effectiveness of 21 alternativecervical cancer screening (CCS) strategies.

Exercise Testing for the Prediction of Cardiac Events in Patients with Diabetes

May 01, 2009

| Bing Guo, Christa Harstall

The objective of this report is to assess research evidence on the safety and prognostic value of exercise testing (including electrocardiogram exercise testing and cardiopulmonary exercise testing) for the prediction of cardiac events in patients with chronic diseases including diabetes, chronic obstructive pulmonary disease (COPD), and arthritis. Information Specialist: Trish…

Human papillomavirus (HPV) Testing in Alberta

May 01, 2009

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is about testing for Human Papillomavirus (HPV). HPV is one of the most common sexually transmitted infections and can also cause cervical cancer. Cervical screening aims to reduce cervical cancer incidence and mortality by detecting precancerous lesions early. Until…

Screening Newborns for Cystic Fibrosis

February 13, 2007

| Bing Guo

A successful screening program for cystic fibrosis (CF) refers to the ability of the program to appropriately identify and refer for care those with CF, while meeting the needs of those who do not have CF, particularly those infants identified by the screening program as carriers (individuals unaffected by CF but have a mutation in one of their CFTR genes). Some measures of success…

Screening Newborns for Hearing

February 13, 2007

| IHE Institute of Health Economics

The use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening. Permanent congenital hearing impairment/loss (PCHI) is one of the most common congenital anomalies found at birth which can be expected to lead to delays and deficits in the development of speech, language, cognition and learning, as well as secondary effects on the…

Image-Guided Vacuum-Assisted Breast Biopsy (IGVB) Economic Analysis

June 11, 2006

| Arto Ohinmaa, Egon Jonsson, Philip Jacobs

Institute of Health Economics Working Paper WP 06-02. The purpose of this report is to examine the economic implications for the province if a supplement to the fee schedule were allowed for vacuum-assisted biopsies. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format…

Mammography screening - mortality rate reduction and screening interval

June 01, 2000

| Christa Harstall

Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…

  • Site Map
  • Privacy Policy
  • Contact Us & Subscribe
  • Home

Copyright © 2017 Institute of Health Economics

Institute of Health Economics 1200 10405 Jasper Avenue Edmonton, AB, Canada T5J 3N4

P: (1) 780.448.4881 F: (1) 780.448.0018
Email: info@ihe.ca

Links

Canada

United States

United Kingdom

Other International

Journals

Health Economics Resources

Free Database Access

Never miss an update!

Subscribe to IHE